About 10% of ovarian cancer patients inherit a familial predisposition, and of those cases, only 35–50% can be attributed to the inheritance of defects in the BRCA1 and BRCA2 tumor suppressor genes [1,2]. The gene discussed is BRCA2; the disease is ovarian carcinoma.